Science News from #BCVS26
Shaping the Future of Cardiovascular Medicine: Integrating Basic Science Breakthroughs to Clinical Impact
July 13–16, 2026
Sheraton Boston | Boston, Massachusetts
Welcome to Boston!
We're so glad you could join us for the American Heart Association's Basic Cardiovascular Sciences 2026 Scientific Sessions. On this page, you'll find exclusive interviews with some of the top scientists presenting at our conference. Keep checking back through the conference as more interviews are posted.
Obesity Metabolic Syndrome and HFpEF
Heart failure with preserved ejection fraction increasingly driven by severe obesity, affects millions worldwide and lacks well-defined mechanisms and effective therapies. However, findings from a landmark study recently published in Science suggest that higher body mass index (BMI) is associated with impaired sarcomere function despite preserved ejection fraction. One of the study investigators, David A. Kass, MD, FAHA, discussed the findings and their implications for molecular targeting and reversibility with weight loss during a featured session on day one of BCVS 2026. In this related interview, moderated by Susmita Sahoo, PhD, Dr. Kass and Dr. Sahoo further explore the study design, potential mechanisms, biomarkers, and therapeutic insights arising from this work.